472 A Biomarker Study of Poly(ADP-ribose) Polymerase Inhibitor (PARPi) ABT-888 Activity On Ex Vivo Tissue From Ovarian Cancer Patients

MLA

Weberpals, J., et al. “472 A Biomarker Study of Poly(ADP-Ribose) Polymerase Inhibitor (PARPi) ABT-888 Activity On Ex Vivo Tissue From Ovarian Cancer Patients.” European Journal of Cancer, vol. 48, Nov. 2012, p. 146. EBSCOhost, https://doi.org/10.1016/S0959-8049(12)72270-0.

APA

Weberpals, J., Ma, X., Dimitroulakos, J., Djordjevic, B., Lapointe-Milot, K., Al Mutairi, N., Pelletier, L., Oza, A., & Squire, J. (2012). 472 A Biomarker Study of Poly(ADP-ribose) Polymerase Inhibitor (PARPi) ABT-888 Activity On Ex Vivo Tissue From Ovarian Cancer Patients. European Journal of Cancer, 48, 146. https://doi.org/10.1016/S0959-8049(12)72270-0

Chicago

Weberpals, J., X. Ma, J. Dimitroulakos, B. Djordjevic, K. Lapointe-Milot, N. Al Mutairi, L. Pelletier, A. Oza, and J. Squire. 2012. “472 A Biomarker Study of Poly(ADP-Ribose) Polymerase Inhibitor (PARPi) ABT-888 Activity On Ex Vivo Tissue From Ovarian Cancer Patients.” European Journal of Cancer 48 (November): 146. doi:10.1016/S0959-8049(12)72270-0.